1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with barium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dusting, GJ; Jiang, F | 1 |
Martin, W; McNeish, AJ; Wilson, WS | 1 |
Graier, WF; Groschner, K; Malli, R; Schmidt, K; Thyagarajan, B | 1 |
3 other study(ies) available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and barium
Article | Year |
---|---|
Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.
Topics: Acetylcholine; Animals; Barium; Charybdotoxin; Dose-Response Relationship, Drug; Endothelium; Enzyme Inhibitors; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Ouabain; Oxadiazoles; Potassium; Quinoxalines; Rats; Rats, Inbred WKY; Renal Artery; Vasodilation; Vasodilator Agents | 2001 |
Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Barium; Biological Factors; Blood Vessels; Bradykinin; Cattle; Charybdotoxin; Ciliary Body; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Eye; Flurbiprofen; Glyburide; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Ouabain; Oxadiazoles; Perfusion; Potassium; Potassium Channel Blockers; Pressure; Quinoxalines; Tetraethylammonium; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Nitric oxide inhibits capacitative Ca2+ entry by suppression of mitochondrial Ca2+ handling.
Topics: Barium; Calcium; Cell Line; Cyclic GMP; Diethylamines; Dose-Response Relationship, Drug; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Oxadiazoles; Oxygen Consumption; Peroxynitrous Acid; Quinoxalines; Thapsigargin; Time Factors | 2002 |